BRCA1 and ovarian neoplasm: This is best illustrated by the requirement of POLQ for the survival of BRCA1/2 mutant cancer cell lines [14,15], and the upregulation of POLQ in BRCA1/2 deficient breast and ovarian tumors [14,20,21].